포스트바이오틱스 식품 원료 시장 예측(-2034년) : 원료 유형, 미생물원, 기능적 효능, 용도, 형태 및 지역별 세계 분석

According to Stratistics MRC, the Global Postbiotic Food Ingredients Market is accounted for $0.5 billion in 2026 and is expected to reach $2.15 billion by 2034 growing at a CAGR of 20.0% during the forecast period. Postbiotic Food Ingredients comprise preparations containing inactivated microorganisms, microbial components, or metabolites produced through microbial fermentation that are incorporated into foods and beverages for functional or nutritional purposes. Unlike probiotics, postbiotic ingredients do not require live microorganisms to remain viable throughout product storage and consumption. They can be incorporated into functional beverages, dairy products, nutritional foods, supplements, and other formulations. Their potential advantages include improved formulation stability and compatibility with products exposed to processing or storage conditions that may affect live cultures. Growing interest in microbiome science is supporting research and commercialization of postbiotic ingredients. Manufacturers are exploring applications related to digestive, immune, and general wellness. Advances in fermentation, microbial characterization, stabilization, and ingredient processing are expanding opportunities for postbiotic food formulations.

Market Dynamics

Driver:

Growing consumer demand for gut health and immunity

Increasing consumer demand for gut health and immune support is driving adoption of postbiotic food ingredients. Growing awareness of the role of postbiotics in health supports market expansion. Advances in research on postbiotics and their benefits drive product development. Rising prevalence of digestive and immune health issues accelerates product adoption. Postbiotics are emerging as key functional ingredients.

Restraint:

Limited awareness and regulatory challenges

Limited consumer awareness of postbiotic benefits and regulatory challenges present barriers to market growth. Regulatory frameworks for postbiotics vary significantly across regions. Price premiums for postbiotic-fortified products may limit mass-market appeal. Technical challenges in formulation affect product development. Consumer skepticism regarding postbiotic benefits may affect adoption.

Opportunity:

Innovation in postbiotic ingredients and formulations

Innovation in postbiotic ingredients and formulations presents significant growth opportunities. Development of postbiotics with improved stability and functionality is expanding applications. Growing availability of clinically studied postbiotics is building consumer confidence. Partnerships with food and beverage manufacturers accelerate product development. Technology advances continue improving postbiotic functionality.

Threat:

Competition from probiotics and prebiotics

Competition from probiotics and prebiotics may limit adoption of postbiotic ingredients. Economic pressures may affect food manufacturers' investment in postbiotic fortification. Regulatory changes affecting postbiotic claims may impact marketing. Consumer skepticism regarding postbiotic benefits may affect adoption. Market saturation in mature categories may constrain growth.

Covid-19 Impact:

The COVID-19 pandemic increased focus on gut health and immunity, accelerating demand for postbiotic food ingredients. Growing consumer awareness of the gut-immune connection supports market expansion. The post-pandemic period has witnessed sustained interest in postbiotic products. E-commerce channels facilitated product access during lockdowns. Growing focus on preventive health drives product adoption.

The inactivated probiotic cells segment is expected to be the largest during the forecast period

The inactivated probiotic cells segment is expected to account for the largest market share during the forecast period as inactivated probiotic cells offer stability and safety advantages over live probiotics. Growing consumer demand for stable, shelf-stable products drives market expansion. Established research on inactivated cells supports segment leadership. Inactivated probiotic cells are the most widely used postbiotic ingredient.

The Bifidobacterium segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Bifidobacterium segment is predicted to witness the highest growth rate driven by increasing research on Bifidobacterium-derived postbiotics and their health benefits. Growing consumer demand for immune and gut health products supports market expansion. Advances in production technology improve cost competitiveness. Bifidobacterium postbiotics are emerging as key ingredients.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to high consumer demand for gut health products, strong presence of postbiotic ingredient companies, and advanced food industry. The United States hosts major postbiotic ingredient companies with established production capabilities. High disposable incomes and health consciousness reinforce regional market leadership. Growing demand for postbiotic-fortified products drives adoption across the region.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for gut health claims, growing consumer awareness of postbiotics, and increasing demand for functional foods. European Union policies support postbiotic food development. Significant research funding and corporate investment support technology development. Strong health culture drives adoption of postbiotic ingredients across the region.

Key players in the market

Some of the key players in the Postbiotic Food Ingredients Market include ADM, DSM-Firmenich AG, Novonesis A/S, Kerry Group plc, Ingredion Incorporated, Chr. Hansen Holding A/S, Lallemand Inc., Kaneka Corporation, AB-BIOTICS S.A., Paragon Laboratories, SAB Biotherapeutics, Probi AB, OptiBiotix Health plc, Lesaffre, and Postbiotics Plus.

Key Developments:

In May 2025, ADM launched a new generation of postbiotic ingredients with enhanced stability and functionality for gut health applications. The ingredients offer improved shelf-life and efficacy. The development responds to growing demand for postbiotic solutions.

In April 2025, DSM-Firmenich AG announced significant expansion of its postbiotic ingredient portfolio with new products for immune and metabolic health.

Ingredient Types Covered:

• Inactivated Probiotic Cells
• Microbial Metabolites
• Short-Chain Fatty Acids
• Microbial Cell Components
• Fermentation-Derived Compounds
• Other Ingredient Types

Microbial Sources Covered:

• Lactobacillus
• Bifidobacterium
• Lactic Acid Bacteria
• Yeasts
• Other Bacteria
• Other Microbial Sources

Functional Benefits Covered:

• Gut Health
• Immune Support
• Metabolic Health
• Inflammation Management
• Skin Health
• Other Functional Benefits

Applications Covered:

• Dairy & Dairy Alternatives
• Beverages
• Bakery & Confectionery
• Functional Foods
• Infant Nutrition
• Other Applications

Forms Covered:

• Powder
• Liquid
• Capsules
• Granules
• Concentrates
• Other Forms

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Postbiotic Food Ingredients Market, By Ingredient Type

• 5.1 Inactivated Probiotic Cells
• 5.2 Microbial Metabolites
• 5.3 Short-Chain Fatty Acids
• 5.4 Microbial Cell Components
• 5.5 Fermentation-Derived Compounds
• 5.6 Other Ingredient Types

6 Global Postbiotic Food Ingredients Market, By Microbial Source

• 6.1 Lactobacillus
• 6.2 Bifidobacterium
• 6.3 Lactic Acid Bacteria
• 6.4 Yeasts
• 6.5 Other Bacteria
• 6.6 Other Microbial Sources

7 Global Postbiotic Food Ingredients Market, By Functional Benefit

• 7.1 Gut Health
• 7.2 Immune Support
• 7.3 Metabolic Health
• 7.4 Inflammation Management
• 7.5 Skin Health
• 7.6 Other Functional Benefits

8 Global Postbiotic Food Ingredients Market, By Application

• 8.1 Dairy & Dairy Alternatives
• 8.2 Beverages
• 8.3 Bakery & Confectionery
• 8.4 Functional Foods
• 8.5 Infant Nutrition
• 8.6 Other Applications

9 Global Postbiotic Food Ingredients Market, By Form

• 9.1 Powder
• 9.2 Liquid
• 9.3 Capsules
• 9.4 Granules
• 9.5 Concentrates
• 9.6 Other Forms

10 Global Postbiotic Food Ingredients Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 ADM
• 13.2 DSM-Firmenich AG
• 13.3 Novonesis A/S
• 13.4 Kerry Group plc
• 13.5 Ingredion Incorporated
• 13.6 Chr. Hansen Holding A/S
• 13.7 Lallemand Inc.
• 13.8 Kaneka Corporation
• 13.9 AB-BIOTICS S.A.
• 13.10 Paragon Laboratories
• 13.11 SAB Biotherapeutics
• 13.12 Probi AB
• 13.13 OptiBiotix Health plc
• 13.14 Lesaffre
• 13.15 Postbiotics Plus